<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8689093</PMID><DateCompleted><Year>1996</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1217-8950</ISSN><JournalIssue CitedMedium="Print"><Volume>42</Volume><Issue>4</Issue><PubDate><Year>1995</Year></PubDate></JournalIssue><Title>Acta microbiologica et immunologica Hungarica</Title><ISOAbbreviation>Acta Microbiol Immunol Hung</ISOAbbreviation></Journal><ArticleTitle>A higher production of platelet activating factor in ex vivo heterologously secondary dengue-2 virus infections.</ArticleTitle><Pagination><StartPage>403</StartPage><EndPage>407</EndPage><MedlinePgn>403-7</MedlinePgn></Pagination><Abstract><AbstractText>Patients with a dengue-1 virus (DV-1) infection followed by another DV-2 infection were reported to have a higher incidence of dengue haemorrhagic fever (DHF). Mononuclear leukocytes (MNLs) are principal cells for DV replication so that we challenge MNLs obtained from non-immune and previously DV-1-infected donors with DV-2 to mimic primary and heterologously secondary DV-2 infections. Production of platelet activating factor (PAF), thromboxane B2 (TxB2), and prostaglandin D2 (PGD2) by MNLs in the DV-2 infections was measured by radioimmunoassay. We found that MNLs, no matter primary or heterologously secondary exposure to DV-2, could release significant amount of PAF, TxB2, and PGD2. PAF but not TxB2 or PGD2 levels released by MNLs were significantly higher in those obtained from previously DV-1-infected donors (75.8 +/- 28.5 vs 21.2 +/- 13.4 pg/ml; p &lt; 0.05). These results suggest that PAF, which is known to enhance inflammatory reactions and to augment platelet aggregation, may in part participate in the pathogenesis of DHF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>K D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Tri-service General Hospital, Taipei, Taiwan, R.O.C.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>C S</ForeName><Initials>CS</Initials></Author><Author ValidYN="Y"><LastName>Shaio</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Hungary</Country><MedlineTA>Acta Microbiol Immunol Hung</MedlineTA><NlmUniqueID>9434021</NlmUniqueID><ISSNLinking>1217-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010972">Platelet Activating Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>54397-85-2</RegistryNumber><NameOfSubstance UI="D013929">Thromboxane B2</NameOfSubstance></Chemical><Chemical><RegistryNumber>RXY07S6CZ2</RegistryNumber><NameOfSubstance UI="D015230">Prostaglandin D2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010972" MajorTopicYN="N">Platelet Activating Factor</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015230" MajorTopicYN="N">Prostaglandin D2</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013929" MajorTopicYN="N">Thromboxane B2</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8689093</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>